Lantheus Holdings Cost of Goods Sold 2013-2024 | LNTH
Lantheus Holdings annual/quarterly cost of goods sold history and growth rate from 2013 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Lantheus Holdings cost of goods sold for the quarter ending December 31, 2024 was $0.143B, a 14.85% increase year-over-year.
- Lantheus Holdings cost of goods sold for the twelve months ending December 31, 2024 was $0.546B, a 7.03% decline year-over-year.
- Lantheus Holdings annual cost of goods sold for 2024 was $0.546B, a 7.03% decline from 2023.
- Lantheus Holdings annual cost of goods sold for 2023 was $0.587B, a 66.09% increase from 2022.
- Lantheus Holdings annual cost of goods sold for 2022 was $0.353B, a 48.77% increase from 2021.
Lantheus Holdings Annual Cost of Goods Sold (Millions of US $) |
2024 |
$546 |
2023 |
$587 |
2022 |
$353 |
2021 |
$238 |
2020 |
$201 |
2019 |
$173 |
2018 |
$168 |
2017 |
$169 |
2016 |
$164 |
2015 |
$158 |
2014 |
$176 |
2013 |
$206 |
2012 |
$213 |
Lantheus Holdings Quarterly Cost of Goods Sold (Millions of US $) |
2024-12-31 |
$143 |
2024-09-30 |
$137 |
2024-06-30 |
$138 |
2024-03-31 |
$128 |
2023-12-31 |
$124 |
2023-09-30 |
$120 |
2023-06-30 |
$119 |
2023-03-31 |
$224 |
2022-12-31 |
$96 |
2022-09-30 |
$92 |
2022-06-30 |
$86 |
2022-03-31 |
$80 |
2021-12-31 |
$72 |
2021-09-30 |
$59 |
2021-06-30 |
$55 |
2021-03-31 |
$51 |
2020-12-31 |
$56 |
2020-09-30 |
$52 |
2020-06-30 |
$40 |
2020-03-31 |
$53 |
2019-12-31 |
$45 |
2019-09-30 |
$44 |
2019-06-30 |
$41 |
2019-03-31 |
$42 |
2018-12-31 |
$42 |
2018-09-30 |
$44 |
2018-06-30 |
$42 |
2018-03-31 |
$40 |
2017-12-31 |
$43 |
2017-09-30 |
$41 |
2017-06-30 |
$43 |
2017-03-31 |
$42 |
2016-12-31 |
$40 |
2016-09-30 |
$39 |
2016-06-30 |
$42 |
2016-03-31 |
$43 |
2015-12-31 |
$38 |
2015-09-30 |
$40 |
2015-06-30 |
$41 |
2015-03-31 |
$39 |
2014-12-31 |
|
2014-09-30 |
$44 |
2014-06-30 |
$45 |
2013-12-31 |
|
2012-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$7.447B |
$1.534B |
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.
|